Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, Borst P.

Cancer Res. 1997 Aug 15;57(16):3537-47.

2.

Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR?

Borst P, Kool M, Evers R.

Semin Cancer Biol. 1997 Jun;8(3):205-13. Review.

PMID:
9441949
3.

[Analysis of xenobiotic detoxification system mediated by efflux transporters].

Suzuki H.

Yakugaku Zasshi. 1999 Nov;119(11):822-34. Review. Japanese.

PMID:
10590710
4.

Multidrug resistance-associated protein subfamily transporters and drug resistance.

Kuwano M, Toh S, Uchiumi T, Takano H, Kohno K, Wada M.

Anticancer Drug Des. 1999 Apr;14(2):123-31. Review.

PMID:
10405639
5.

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.

Zhou SF, Wang LL, Di YM, Xue CC, Duan W, Li CG, Li Y.

Curr Med Chem. 2008;15(20):1981-2039. Review.

PMID:
18691054
6.

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R.

Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. Review.

PMID:
10739113
7.

Regulation of organic anion transport in the liver.

Roelofsen H, Müller M, Jansen PL.

Yale J Biol Med. 1997 Jul-Aug;70(4):435-45. Review.

8.

A family of drug transporters: the multidrug resistance-associated proteins.

Borst P, Evers R, Kool M, Wijnholds J.

J Natl Cancer Inst. 2000 Aug 16;92(16):1295-302. Review.

9.

Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein.

Müller M, Roelofsen H, Jansen PL.

Semin Liver Dis. 1996 May;16(2):211-20. Review.

PMID:
8781025
10.

The role of multidrug transporters in drug availability, metabolism and toxicity.

Bodó A, Bakos E, Szeri F, Váradi A, Sarkadi B.

Toxicol Lett. 2003 Apr 11;140-141:133-43. Review.

PMID:
12676459
11.

Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2.

Suzuki H, Sugiyama Y.

Semin Liver Dis. 1998;18(4):359-76. Review.

PMID:
9875554
12.
13.

[Mechanisms for resistance to anticancer agents and the reversal of the resistance].

Akiyama S, Chen ZS, Kitazono M, Sumizawa T, Furukawa T, Aikou T.

Hum Cell. 1999 Sep;12(3):95-102. Review. Japanese.

PMID:
10695015
15.

[ATP-dependent glutathione conjugate export pump].

Furukawa T, Chen ZS, Akiyama S.

Nihon Rinsho. 1997 May;55(5):1083-90. Review. Japanese.

PMID:
9155157
16.

MRP subfamily transporters and resistance to anticancer agents.

Kruh GD, Zeng H, Rea PA, Liu G, Chen ZS, Lee K, Belinsky MG.

J Bioenerg Biomembr. 2001 Dec;33(6):493-501. Review.

PMID:
11804191
17.

Role of MRP4 and MRP5 in biology and chemotherapy.

Sampath J, Adachi M, Hatse S, Naesens L, Balzarini J, Flatley RM, Matherly LH, Schuetz JD.

AAPS PharmSci. 2002;4(3):E14. Review.

18.

Molecular cytogenetics of multiple drug resistance.

Schoenlein PV.

Cytotechnology. 1993;12(1-3):63-89. Review.

PMID:
7765332
19.

Cisplatin resistance in human cancers.

Scanlon KJ, Kashani-Sabet M, Tone T, Funato T.

Pharmacol Ther. 1991 Dec;52(3):385-406. Review.

PMID:
1820582
20.

Mammalian multidrug-resistance proteins (MRPs).

Slot AJ, Molinski SV, Cole SP.

Essays Biochem. 2011 Sep 7;50(1):179-207. doi: 10.1042/bse0500179. Review.

PMID:
21967058
Items per page

Supplemental Content

Write to the Help Desk